Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: Volume and neuronal number for the output, internal relay, and striatal modulating nuclei

Journal of Comparative Neurology

Volumn 445, Issue 3, 2002, Pages 238-255

  Hardman, Craig Denis ^a   Henderson, Jasmine Monica ^b   Finkelstein, David Isaac ^b   Horne, Malcolm Kenneth ^c   Paxinos, George ^d   Halliday, Glenda Margaret ^e  

^a Department of Tropical Medicine ^*  (United States)

^b DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d RESEARCH AND DEVELOPMENT   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Calcium binding proteins; Fractionator; Globus pallidus; Neuropeptides; Substantia nigra; Subthalamic nucleus

Indexed keywords

CALCIUM BINDING PROTEIN; NEUROPEPTIDE; PARVALBUMIN;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BABOON; BASAL GANGLION; BRAIN SIZE; CELL COUNT; CELL FRACTIONATION; CELL VOLUME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GLOBUS PALLIDUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MACACA; MARMOSET; NERVE CELL; NISSL SUBSTANCE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; CALLITHRIX; CELL COUNT; FEMALE; GLOBUS PALLIDUS; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA NEMESTRINA; MALE; NEURONS; PAPIO; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 0037041286     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10165     Document Type: Article

References (79)

1. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing
2. Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus
3. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys
4. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
5. Staging of Alzheimer's disease-related neurofibrillary changes
6. Efferent fiber projections of the subthalamic nucleus in the rhesus monkey. A comparison of the efferent projections of the subthalamic nucleus, substantia nigra and globus pallidus
7. Interconnections and organization of pallidal and subthalamic nucleus neurons in the monkey
8. Connections of the subthalamic nucleus in the monkey
9. Parvalbumin as a marker of fast firing neurons
10. Calbindin D-28k and parvalbumin in the rat nervous system
11. A consideration of neural counting methods
12. Extrastriatal dopaminergic innervation of human basal ganglia
13. MPTP-induced parkinsonism in the monkey: Neurochemical pathology, complications of treatment and pathophysiological mechanisms
14. Substance P and enkephalin containing pathways
15. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
16. Ageing and Parkinson's disease: Substantia nigra regional selectivity
17. Axonal sprouting following lesions of the rat substantia nigra
18. Comparative volumetric studies on pallidum in insectivores and primates. Evolutionary aspects
19. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems
20. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems
21. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease
22. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat
23. Neurotransmitters and neuromodulators in basal ganglia
24. The nigrostriatal system in Parkinson's disease
25. Striosomes and matrisomes
26. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra
27. Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease
28. A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy
29. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy
30. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease
31. Substantia nigra pars reticulata neurons in Parkinson's disease
32. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata
33. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy
34. Volumetric comparisons of the basal ganglia of various primates including man
35. Behavioural effects of subthalamic nucleus lesions in the hemiparkinsonian marmoset (Callithrixjacchus)
36. Cholinergic innervation in the human striatum: A three compartment model
37. Neurochemical architecture of the human striatum
38. Parvalbumin and calbindin D-28k in the entopeduncular nucleus, subthalamic nucleus, and substantia nigra of the rat as revealed by double-immunohistochemical methods
39. Distribution of calbindin D-28k and parvalbumin neurons and fibers in the rat basal ganglia
40. The connection of the dopaminergic system with the striatum in rats and primates: An analysis with respect to the functional and compartmental organization of the striatum
41. Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin
42. Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with PHA-L method
43. Pallidal inputs to subthalamus: Intracellular analysis
44. Species-dependence and relationship of morphological and electrophysiological properties in nigral compacta neurons
45. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
46. Preservation of midbrain catecholaminergic neurons in very old human subjects
47. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms
48. Morphometric studies of the neuropathological changes in choreatic disease
49. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders
50. Unbiased morphometrical measurements show loss of pigmented nigral neurons with ageing
51. Rate of cell death in Parkinsonism indicates active neuropathological process
52. Calbindin D28K-containing neurons are restricted to the medial substantia nigra in humans
53. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human
54. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans
55. The midbrain dopaminergic cell groups in the baboon Papio ursinus
56. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease
57. An autoradiographic study of cortical projections from motor thalamic nuclei in the macaque monkey
58. An autoradiographic study of cortical projections from the motor thalamic nuclei in the macaque monkey
59. Projections of the lentiform nucleus in the monkey
60. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: A stereological study using the Cavalieri and optical dissector methods
61. The absolute number of nerve cells in the substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
62. Functional anatomy of the basal ganglia. I. The cortical-basal ganglia-thalamo-cortical loop
63. Chemical anatomy of primate basal ganglia
64. Calcium binding proteins in the primate basal ganglia
65. The primate motor thalamus analyzed with reference to subcortical afferent territories
66. The basal ganglia related system of primates: Definition, description and information analysis
67. The primate motor thalamus
68. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat
69. Morphological features of neurons containing calcium-binding proteins in the human striatum
70. Structural and functional evolution of the basal ganglia in vertebrates
71. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans
72. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas
73. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity
74. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication of MK-801 treatment: A stereological estimate of neuronal loss
75. Comparative volumetric studies on striatum in insectivores and primates. Evolutionary aspects
76. Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease
77. Local inactivation of the sensorimotor territories of the internal segment of the globus pallidus and the subthalamic nucleus alleviates parkinsonian motor signs in MPTP monkeys
78. The organization of the striatal output system: A single-cell juxtacellular labeling study in the rat